Enantia
Pre-clinicalEnantia is a CRO with 20+ years of experience in chemical and solid-state solutions, with small molecules, highly potent API and controlled substances capabilities.
Founded
2003
Focus
Small MoleculesDrug Delivery
About
Enantia is a CRO with 20+ years of experience in chemical and solid-state solutions, with small molecules, highly potent API and controlled substances capabilities.
Funding History
2Total raised: $12.8M
Series A$12MCaixa Capital RiscSep 15, 2022
Grant$800KSpanish Ministry of ScienceMay 15, 2020
Company Info
TypePrivate
Founded2003
LocationBarcelona, Spain
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile